Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement

…, R Horsburgh, B Molina-Moya… - … of tuberculosis and …, 2016 - ingentaconnect.com
The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as the …

Management of patients with multidrug-resistant tuberculosis

…, AM Mandalakas, B Molina-Moya… - … of tuberculosis and …, 2019 - ingentaconnect.com
The emergence of multidrug-resistant tuberculosis (MDR-TB; defined as resistance to at least
rifampicin and isoniazid) represents a growing threat to public health and economic growth…

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

…, M Merker, P Miotto, B Molina-Moya… - The Lancet Infectious …, 2023 - thelancet.com
Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-based
methods being considered the gold standard for drug susceptibility testing, molecular …

[HTML][HTML] Acute phase proteins and IP-10 as triage tests for the diagnosis of tuberculosis: systematic review and meta-analysis

…, K Kontogianni, ER Adams, B Molina-Moya… - Clinical Microbiology …, 2019 - Elsevier
Objectives We examined the data reported in studies for diagnostic purposes and to discuss
whether their intended use could be extended to triage, as rule-in or rule-out tests to select …

[HTML][HTML] Multidrug-and extensively drug-resistant Mycobacterium tuberculosis Beijing clades, Ukraine, 2015

…, E Nikolaevskaya, TA Kohl, B Molina-Moya… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) is an emerging
threat to TB control in Ukraine, a country with the third highest XDR TB burden globally. …

[HTML][HTML] Molecular Detection of Mycobacterium tuberculosis in Oral Mucosa from Patients with Presumptive Tuberculosis

B Molina-Moya, N Ciobanu, M Hernandez… - Journal of clinical …, 2020 - mdpi.com
Tuberculosis (TB) diagnosis is increasingly based on the detection of Mycobacterium
tuberculosis complex (MTBC) DNA in sputum using molecular diagnostic tests as the first test for …

AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples

B Molina-Moya, A Lacoma, C Prat, J Diaz, A Dudnyk… - Journal of Infection, 2015 - Elsevier
Objectives To determine the sensitivity and specificity of AID TB Resistance line probe assay
(AID Diagnostika, Germany) to detect Mycobacterium tuberculosis and its resistance to first- …

[HTML][HTML] Diagnostic performance of the Fujifilm SILVAMP TB-LAM in children with presumptive tuberculosis

P Comella-del-Barrio, B Molina-Moya, J Gautier… - Journal of clinical …, 2021 - mdpi.com
Current diagnostics for tuberculosis (TB) only manage to confirm a small proportion of children
with TB and require respiratory samples, which are difficult to obtain. There is a need for …

[HTML][HTML] Measuring T-cell responses against SARS-CoV-2 is of utility for disease and vaccination management

…, C Pérez-Cano, A Lacoma, B Molina-Moya… - Journal of Clinical …, 2022 - mdpi.com
The measurement of specific T-cell responses can be a useful tool for COVID-19 diagnostics
and clinical management. In this study, we evaluated the IFN-γ T-cell response against the …

Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance

B Molina-Moya, A Lacoma, C Prat, E Pimkina, J Diaz… - Journal of Infection, 2015 - Elsevier
Objective To study the diagnostic accuracy of a multiplex real-time PCR (Anyplex II MTB/MDR/XDR,
Seegene, Corea) that detects Mycobacterium tuberculosis resistant to isoniazid (INH)…